IL227377A0 - Combinations - Google Patents

Combinations

Info

Publication number
IL227377A0
IL227377A0 IL227377A IL22737713A IL227377A0 IL 227377 A0 IL227377 A0 IL 227377A0 IL 227377 A IL227377 A IL 227377A IL 22737713 A IL22737713 A IL 22737713A IL 227377 A0 IL227377 A0 IL 227377A0
Authority
IL
Israel
Prior art keywords
combinations
Prior art date
Application number
IL227377A
Other languages
English (en)
Hebrew (he)
Original Assignee
Univ Texas
Glaxosmithkline Intellectual Property Ltd
Glaxosmithkline Ip No 2 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Glaxosmithkline Intellectual Property Ltd, Glaxosmithkline Ip No 2 Ltd filed Critical Univ Texas
Publication of IL227377A0 publication Critical patent/IL227377A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL227377A 2011-01-26 2013-07-08 Combinations IL227377A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161436435P 2011-01-26 2011-01-26
PCT/US2012/022638 WO2012103276A1 (en) 2011-01-26 2012-01-26 Combinations

Publications (1)

Publication Number Publication Date
IL227377A0 true IL227377A0 (en) 2013-09-30

Family

ID=46581159

Family Applications (1)

Application Number Title Priority Date Filing Date
IL227377A IL227377A0 (en) 2011-01-26 2013-07-08 Combinations

Country Status (13)

Country Link
US (2) US20130296356A1 (enExample)
EP (1) EP2667871A4 (enExample)
JP (1) JP2014503589A (enExample)
KR (1) KR20140011322A (enExample)
CN (1) CN103476413B (enExample)
AU (1) AU2012209100A1 (enExample)
BR (1) BR112013018565A2 (enExample)
CA (1) CA2825790A1 (enExample)
EA (1) EA201391076A1 (enExample)
IL (1) IL227377A0 (enExample)
MX (1) MX2013008654A (enExample)
SG (1) SG191926A1 (enExample)
WO (1) WO2012103276A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150335609A1 (en) * 2012-02-17 2015-11-26 Pharmacyclics, Inc. Combinations of histone deacetylase inhibitor and pazopanib and uses thereof
BR112015008155A2 (pt) * 2012-10-12 2017-07-04 Glaxosmithkline Llc combinações
EP2908816A4 (en) * 2012-10-22 2016-06-15 Novartis Ag ASSOCIATION
US20150306099A1 (en) * 2012-11-27 2015-10-29 Glaxosmithkline Llc Combination
KR20250052367A (ko) * 2022-08-24 2025-04-18 인엑스메드 (난징) 컴퍼니 리미티드 Fak 억제제와 미세소관 억제제의 약제학적 병용물 및 이의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034860B2 (en) * 2006-07-21 2011-10-11 Eastman Specialties Holdings Corporation Organosol plastisol compositions
US8501763B2 (en) * 2007-03-16 2013-08-06 The Scripps Research Institute Inhibitors of focal adhesion kinase
JP5551689B2 (ja) * 2008-06-17 2014-07-16 アストラゼネカ アクチボラグ ピリジン化合物
WO2010036796A1 (en) * 2008-09-26 2010-04-01 Concert Pharmaceuticals, Inc. Pyridineamine derivatives
JO3067B1 (ar) * 2008-10-27 2017-03-15 Glaxosmithkline Llc بيرميدينات بيرازولو امينو كمثبطات ل fak

Also Published As

Publication number Publication date
KR20140011322A (ko) 2014-01-28
JP2014503589A (ja) 2014-02-13
CN103476413A (zh) 2013-12-25
WO2012103276A1 (en) 2012-08-02
CN103476413B (zh) 2016-03-16
EP2667871A4 (en) 2014-07-09
US20160067248A1 (en) 2016-03-10
US20130296356A1 (en) 2013-11-07
CA2825790A1 (en) 2012-08-02
EA201391076A1 (ru) 2014-07-30
EP2667871A1 (en) 2013-12-04
MX2013008654A (es) 2013-09-02
BR112013018565A2 (pt) 2016-09-27
SG191926A1 (en) 2013-08-30
AU2012209100A1 (en) 2013-08-01

Similar Documents

Publication Publication Date Title
GB201307749D0 (en) Colonoscopy-preparation
EP2695208A4 (en) MICRO-THERMOCOUPLE
HUE038998T2 (hu) Hipoallergén
GB201216828D0 (en) Centraler
IL227377A0 (en) Combinations
DK2770906T3 (en) Applanationstonometer
GB201104730D0 (en) Therabra
GB201106465D0 (en) Cyclobuggy
GB201100001D0 (en) TidySqueeze2
HUE040659T2 (hu) Plazmaforrás
GB201122051D0 (en) Polyester-II
GB201116819D0 (en) TravelApp
GB201104857D0 (en) Floodstop
GB201109292D0 (en) Glycodendrimers
GB201104492D0 (en) Magna-spin
GB201104258D0 (en) BallOnT
GB201102977D0 (en) Cyclobuggy
IL210848A0 (en) Mahiticket
GB201109219D0 (en) Invisilight
GB201108851D0 (en) Wangle spanglers
GB201107437D0 (en) REZio
GB201102679D0 (en) Ex-connector
GB201108654D0 (en) Extremitee
GB201122212D0 (en) GPH-loop
GB201107161D0 (en) Corcost-ZZ600